logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. National Institute of Oncology

Source: Site record.
http://www.onkol.hu

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The National Institute of Oncology (OOI – Országos Onkológiai Intézet) is Hungary’s leading specialized cancer center, located in Budapest. It is the country’s central institution for cancer prevention, diagnosis, treatment, and oncology research, and serves as a national referral hub for complex cancer cases. The institute provides comprehensive oncology services, including medical oncology, surgical oncology, radiotherapy, diagnostic imaging, nuclear medicine, and palliative care. It is especially known for advanced treatments such as precision radiotherapy, targeted therapies, and multidisciplinary tumor boards that design individualized treatment plans for patients. OOI also plays a major role in clinical research and cancer epidemiology, contributing to international oncology trials and developing national cancer control strategies. It is closely connected with academic institutions and medical universities, making it an important training center for oncologists and…

Source: Trial-derived.
16Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
0Completed Trials
Source: Trial-derived.
16Unique Conditions
Source: Trial-derived.
25Unique Sponsors

Conditions

Source: Trial-derived. Cervical Cancer (2)Source: Trial-derived. Squamous Cell Carcinoma of the Head and Neck (2)Source: Trial-derived. Castration-Resistant Prostatic Cancer (1)Source: Trial-derived. Colorectal Cancer (1)Source: Trial-derived. Diffuse Large B-cell Lymphoma (1)Source: Trial-derived. Follicular Lymphoma (1)Source: Trial-derived. Locally Advanced or Metastatic Pancreatic Cancer (1)Source: Trial-derived. Lymphoma (1)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (4)Source: Trial-derived. Merck KGaA, Darmstadt, Germany (2)Source: Trial-derived. Pfizer (2)Source: Trial-derived. AB Science (1)Source: Trial-derived. Alliance Foundation Trials, LLC. (1)Source: Trial-derived. ARCAGY/ GINECO GROUP (1)Source: Trial-derived. Bitop AG (1)Source: Trial-derived. Breast International Group (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. CT Scan
Source: AI-inferred. SPECT / nuclear medicine

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Intensity-modulated radiation therapy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot